Repurposed cancer drug shows promise for Parkinson’s

Repurposed cancer drug shows promise for Parkinson’s
Researchers at the Oxford Parkinson’s Disease Centre, UK, have repurposed an experimental cancer drug – called tasquinimod – as a potential treatment for Parkinson’s. The study – funded by Parkinson’s UK and published in science journal ‘Cell Stem Cell’ – has been tested on a total of 10 patients so far. As part of the research, the study grew brain ... read more
Source: Parkinson’s Life EUPublished on 2018-12-05By admin